Lower-neck involvement and post–concurrent chemoradiotherapy response predict distant metastasis in head and neck cancer
Radiation Oncology Journal · 30.06.2026 · 44 (2) · 117-125
DOI: 10.3857/roj.2026.00220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Radiation Oncology Journal, erschienen am 30.06.2026. Verfasst von Dongchan Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Pusan National University Hospital, Busan, Republic of Korea. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Pusan National University Hospital.
Abstract (Originalsprache)
Purpose
This study aimed to evaluate whether lower-neck involvement and post–concurrent chemoradiotherapy (CCRT) response predict distant metastasis (DM) in patients with head and neck squamous cell carcinoma (HNSCC) treated with definitive intensity-modulated radiotherapy (IMRT)–based CCRT.Materials and Methods: We retrospectively analyzed 210 patients with non-metastatic HNSCC treated with definitive IMRT-based CCRT between 2009 and 2020. Lower-neck involvement was defined as radiologic involvement of inferior cervical lymph nodes. Post-treatment response was categorized as complete response (CR) versus non-CR. Logistic and Cox regression models were used to identify predictors of DM and survival outcomes.
Results
At a median follow-up of 59.8 months, DM developed in 51 patients (24.3%). In multivariable logistic analysis, lower-neck involvement (odds ratio [OR], 2.32; 95% confidence interval [CI], 1.18 to 4.54; p = 0.014) and non-CR (OR, 2.57; 95% CI, 1.31 to 5.05; p = 0.006) independently predicted DM. In Cox analyses, lower-neck involvement was associated with inferior distant metastasis-free survival (DMFS) (hazard ratio [HR], 2.07; 95% CI, 1.15 to 3.75; p = 0.016) and progression-free survival (PFS) (HR, 1.93; 95% CI, 1.19 to 3.14; p = 0.008), whereas non-CR predicted worse DMFS (HR, 2.71; 95% CI, 1.49 to 4.95; p = 0.001), PFS (HR, 3.77; 95% CI, 2.25 to 6.33; p < 0.001), and overall survival (HR, 5.08; 95% CI, 1.94 to 13.34; p < 0.001).
Conclusion
Lower-neck involvement and post-CCRT response independently predict DM after definitive CCRT for HNSCC and may improve risk stratification for systemic failure.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Pusan National University Hospital, Busan, Republic of Korea.
- Department of Radiation Oncology, Pusan National University School of Medicine, Yangsan, Republic of Korea.
- Department of Radiation Oncology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.
Förderung
- Pusan National University Hospital
Zitieren
APA
Kim, D., Kim, D., Kim, W., Nam, J., Park, D., Ki, Y., Joo, J., Lee, K., & Pak, S. (2026). Lower-neck involvement and post–concurrent chemoradiotherapy response predict distant metastasis in head and neck cancer. Radiation Oncology Journal, 44(2), 117-125. https://doi.org/10.3857/roj.2026.00220
Vancouver
Kim D, Kim D, Kim W, Nam J, Park D, Ki Y, et al. Lower-neck involvement and post–concurrent chemoradiotherapy response predict distant metastasis in head and neck cancer. Radiation Oncology Journal. 2026;44(2):117-125. doi:10.3857/roj.2026.00220
BibTeX
@article{Kim2026,
author = {Kim, Dongchan and Kim, Donghyun and Kim, Wontaek and Nam, Jiho and Park, Dahl and Ki, Yongkan and Joo, Jihyeon and Lee, Kyeonghyo and Pak, Sangil},
title = {Lower-neck involvement and post–concurrent chemoradiotherapy response predict distant metastasis in head and neck cancer},
journal = {Radiation Oncology Journal},
year = {2026},
volume = {44},
number = {2},
pages = {117--125},
doi = {10.3857/roj.2026.00220}
}
EUVIMED